Skip to main content

Table 3 Convergent and divergent validity analysis with UF-DBD and reference measures (monthly sum scores)

From: Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

Spearman Rank Correlation Coefficient of UF-DBD monthly sum score to RND EOT
N rs N rs
UF-DSD v3 monthly average total scorea 286 0.19 266 0.29
UF-DSD v3 monthly average bloating and swelling domain score 286 0.19 266 0.25
UF-DSD v3 monthly average pain domain score 286 0.17 266 0.32
UF-IS v3 monthly sum total score 262 0.24 250 0.38
UFS-QoL symptom domain score at visit 286 0.11 264 0.42
UFS-QoL HRQoL domain score at visit 281 −0.08 257 −0.36
UFS-QoL concerns related to soiling score at visit 281 0.12 259 0.46
SF-36 v2® physical component domain score at visit 277 −0.07 260 −0.29
SF-36 v2® mental component domain score at visit 278 −0.16 260 −0.24
SF-36 v2® bodily pain subscale score at visit 285 −0.19 264 −0.34
  1. Classification of Spearman rank correlation coefficient rs: Weak correlation: 0.10 < |rs| < 0.30, Moderate correlation: 0.30 ≤ |rs| < 0.50, Strong correlation: 0.50 ≤ |rs| < 1
  2. All patients analyzed here had been enrolled in the ASTEROID 1 study with an existing date of visit
  3. EOT Indicates end of treatment, HRQoL Health-related quality of life, N Number of patients, RND Randomization, rs Spearman rank correlation coefficient, SF-36 v2® Short-Form 36 Health Survey Version 2, UF-DBD Uterine Fibroid Daily Bleeding Diary, UF-DSD v3 Uterine Fibroid Daily Symptom Diary version 3, UF-IS v3 Uterine Fibroid Impact Scale version 3, UFS-QoL Uterine Fibroid Symptom and Quality of Life Questionnaire
  4. aUF-DSD v3 total score with exclusion of item 1 (UF-DBD)